Ole F. Olesen - Concepedia

Author

Ole F. Olesen

European & Developing Countries Clinical Trials Partnership ORCID

Also Known As

O F Olesen, O Olesen, O. F Olesen, O. F. Olesen, O. Olesen, O.F Olesen, O.F. Olesen, Ole F Olesen, Ole F. OLESEN, Ole F. Olesen

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

European & Developing Countries Clinical Trials Partnership Lundbeck (Denmark)World Health Organization Karolinska Institutet University of Cologne

About

Ole F. Olesen is an author at European & Developing Countries Clinical Trials Partnership specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	824
2	Natural Sciences	6	6	228
3	Social Sciences	5	5	434
4	Public Health	3	3	112
5	Language Studies	1	1	21

Ole F. Olesen

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease R. Anthony Crowther, Ole F. Olesen, Ross Jakes, FEBS Letters Protein FunctionAlzheimer's DiseaseMolecular NeuroscienceRepeat RegionPaired Helical Filament	1992	168
Assembly of Alzheimer‐like filaments from full‐length tau protein R. Anthony Crowther, Ole F. Olesen, Michael J. Smith, FEBS Letters Protein AssemblyMolecular BiologyCytoskeletonMicrotubule-associated Protein TauRecombinant Tau Protein	1994	154
Binding of A<i>β</i> to α- and <i>β</i>-synucleins: identification of segments in α-synuclein/NAC precursor that bind A<i>β</i> and NAC Poul Henning Jensen, Peter Højrup, Henrik Hager, Biochemical Journal	1997	144
Developmental expression of α-synuclein in rat hippocampus and cerebral cortex Karen L. Petersen, Ole F. Olesen, Jens D. Mikkelsen Neuroscience Synaptic PlasticityNeurodegenerative DiseasesDevelopmental BiologyMolecular NeuroscienceDevelopmental Expression	1999	121
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons Orestes Vicente Forlenza, J. M. Spink, Rejith Dayanandan, Journal of Neural Transmission Synaptic TransmissionNeurotransmissionGsk-3β InhibitionSynaptic SignalingSocial Sciences	2000	83
High Density Lipoprotein Inhibits Assembly of Amyloid β-Peptides into Fibrils Ole F. Olesen, Lone Dagø Biochemical and Biophysical Research Communications Proteinlipid InteractionBiochemistryProtein FoldingProtein MisfoldingMedicine	2000	75
Strengthening health research capacity in sub-Saharan Africa: mapping the 2012–2017 landscape of externally funded international postgraduate training at institutions in the region Terra Morel, Dermot Maher, Thomas Nyirenda, Globalization and Health	2018	52
Immunity against HIV/AIDS, Malaria, and Tuberculosis during Co-Infections with Neglected Infectious Diseases: Recommendations for the European Union Research Priorities Diana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, PLoS neglected tropical diseases MalariaEpidemiological DynamicDisease OutbreakNeglected InfectiousEmerging Infectious Disease	2008	50
Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent Solomon Nwaka, Alexander Ochem, Dominique Besson, BMC International Health and Human Rights Healthcare ProvisionInstitutional CollaborationDiagnostics InnovationPan-african CentresCompetitive Criteria	2012	49
Amyloid β neurotoxicity in the cholinergic but not in the serotonergic phenotype of RN46A cells Ole F. Olesen, Lone Dagø, Jens D. Mikkelsen Molecular Brain Research Neurodegenerative DiseasesRn46a CellsMedicineNeurotransmitterSerotonergic Phenotype	1998	37

Page 1